EverHint – EMA 10/30 Crossover – Top 15 Buy and Top 5 Sell Signals for Sep 18, 2026
Excerpt: 20 signals (from 56 total). Technology leads (11). price range $11-$721. 4 with insider selling.
What This Signal Is
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
Market Context
The VIX sitting at 14.81, down over 4% on the session, signals a notably calm volatility environment — conditions that tend to compress intraday price swings and reduce the likelihood of false breakouts. For EMA-based crossover strategies like ema10/ema30, this is generally a constructive backdrop. Tighter price action means trending moves, when they do emerge, tend to be more deliberate and sustained rather than erratic, which improves the reliability of crossover signals and reduces whipsaw risk.
Trend direction across the major indices presents a mixed but broadly constructive picture. The S&P 500 and Nasdaq are pushing modestly higher while the Dow lags slightly in negative territory, suggesting that growth and momentum-oriented segments of the market are leading the session. This divergence points to continued risk appetite skewed toward higher-beta, growth-sensitive names rather than value or defensives. With Technology ranking as the top sector for today's signals, this aligns well with the Nasdaq's relative outperformance, reinforcing the case that momentum conditions favor tech-oriented crossover setups.
From a sector rotation standpoint, the concentration of signals in Technology suggests capital continues to flow toward high-growth areas rather than rotating defensively. In a low-volatility, moderate-uptrend environment like today's, EMA crossover signals in leading sectors historically carry stronger follow-through potential, as trend persistence tends to outlast short-term noise. Traders should remain attentive to the Dow's mild underperformance as a signal that breadth is not fully uniform — positioning should favor sectors aligned with the prevailing momentum rather than assuming broad market participation.
🟢 Buy Signals (15 of 18 total)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AMRX | Amneal Pharmaceuticals... | Healthcare | $18.71 | — | $6.0B |
| 2 | BAP | Credicorp Ltd. | Financial Services | $381.83 | — | $30.3B |
| 3 | BLLN | BillionToOne, Inc. | Healthcare | $105.92 | — | $4.9B |
| 4 | CRSP | CRISPR Therapeutics AG | Healthcare | $56.56 | — | $5.5B |
| 5 | CRWD | CrowdStrike Holdings, ... | Technology | $237.65 | Sell -$5,446,986 | $242.0B |
| 6 | HUT | Hut 8 Corp. | Financial Services | $98.74 | — | $11.1B |
| 7 | ISRG | Intuitive Surgical, Inc. | Healthcare | $393.33 | Sell -$9,145 | $139.0B |
| 8 | MSGE | Madison Square Garden ... | Consumer Cyclical | $79.02 | — | $3.7B |
| 9 | MSGS | Madison Square Garden ... | Communication Services | $398.75 | — | $9.6B |
| 10 | MSM | MSC Industrial Direct ... | Industrials | $122.21 | — | $6.8B |
| 11 | MXL | MaxLinear, Inc. | Technology | $81.12 | — | $7.4B |
| 12 | NBIS | Nebius Group N.V. | Communication Services | $223.54 | — | $53.6B |
| 13 | NOK | Nokia Oyj | Technology | $10.69 | — | $57.7B |
| 14 | PSLV | Sprott Physical Silver... | Financial Services | $21.71 | — | $13.8B |
| 15 | QQQ | Invesco QQQ Trust, Ser... | $721.45 | — | $514.1B |
🔴 Sell Signals (5 of 38 total)
Ranked by RSI (higher RSI for sell signals = more overbought)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AR | Antero Resources Corpo... | Energy | $34.86 | — | $10.7B |
| 2 | ARCC | Ares Capital Corporation | Financial Services | $19.40 | — | $13.9B |
| 3 | C | Citigroup Inc. | Financial Services | $131.80 | — | $226.0B |
| 4 | CI | Cigna Corporation | Healthcare | $275.28 | — | $72.7B |
| 5 | COR | Cencora, Inc. | Healthcare | $308.78 | — | $60.1B |
Field Notes
Sector concentration: Technology (11), Healthcare (10), Financial Services (9)
Insider selling (7d): CRWD (CrowdStrike Holdings, Inc., -$5,446,986), ISRG (Intuitive Surgical, Inc., -$9,145)
Data coverage: 7.1% insider (7d), 0.0% congressional (30d), 0.0% earnings, 19.6% news (7d)
Peer Analysis
HUT (Hut 8 Corp.): Leads 5 peers: MC ($59.73), SNEX ($67.00), VIRT ($57.75), RJF ($164.75), LAZ ($35.75)
NOK (Nokia Oyj): Leads 5 peers: ERIC ($10.17), HPE ($60.74), CLS ($332.63), UI ($589.48), GRMN ($273.91)
MSM (MSC Industrial Direct Co., Inc.): Leads 5 peers: POWL ($183.96), SITE ($90.47), OMAB ($97.45), BCO ($106.12), ENS ($178.12)
Recent Headlines
AMRX (Amneal Pharmaceuticals, Inc.)
- Amneal Announces FDA Approval and Launch of Lanreotide Injection
- Amneal receives FDA approval for generic lanreotide injection
ARCC (Ares Capital Corporation)
- How a 60-Year-Old Turned a $910,000 401(k) Rollover Into a $5,650 Monthly Paycheck Without Buying an Annuity
- Investors Heavily Search Ares Capital Corporation (ARCC): Here is What You Need to Know
QQQ (Invesco QQQ Trust, Series 1)
- QQQI’s 14% Monthly Yield Masked $940 in Forgone Gains Per $10,000 Since Inception
Vlad's Take
Today's signals: Strong sector concentration in Technology (11 signals) suggests sector-specific rotation. 4 signals showing insider selling warrant caution.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.